AstraZeneca PLC

AZN

GB0009895292

Pharmaceuticals

Market Closed - London S.E. Other stock markets 11:35:02 2024-05-20 am EDT			5-day change	1st Jan Change
12,096 ^GBX	-0.12%		-2.22%	+14.11%

06:52pm	European Equities Close Higher in Monday Trading; Ryanair May Have to Lower Ticket Prices	MT
06:13pm	European Equities Close Higher in Monday Trading; Ryanair May Have to Lower Ticket Prices	MT

ASTRAZENECA : Deutsche Bank gives a Sell rating

February 09, 2024 at 04:39 am EST

Deutsche Bank is no longer neutral on the stock, its advice is now to sell. The target price is revised downwards from GBX 11000 to GBX 9500.

Latest news about AstraZeneca PLC

European Equities Close Higher in Monday Trading; Ryanair May Have to Lower Ticket Prices	12:52pm	MT
European Equities Close Higher in Monday Trading; Ryanair May Have to Lower Ticket Prices	12:13pm	MT
Global markets live: Apple, Tesla, Pfizer, AstraZeneca, Microsoft...	10:40am
Gold shines amid interest rate cut hopes	06:56am	AN
Amgen and AstraZeneca's Lung Disease Drug Study Reports Mixed Results	06:53am	MT
ASTRAZENECA : Gets a Buy rating from JP Morgan	06:01am	ZD
European Midday Briefing : Stocks, Commodities Gain on Fresh China Policy Support	05:25am	DJ
AstraZeneca: Phase 2 endpoint not met in COPD	04:47am	CF
European stocks start the week on a high	04:39am
AstraZeneca to Build $1.5 Billion Cancer Therapy Manufacturing Facility in Singapore	04:24am	MT
AstraZeneca: new production facility in Singapore	04:18am	CF
AstraZeneca plans to build manufacturing plant in Singapore	03:26am	AN
Keywords would back GBP2.0 billion bid as EQT circles	02:50am	AN
AstraZeneca Plans $1.5 Billion Manufacturing Facility in Singapore	02:49am	DJ
AstraZeneca to Develop $1.5 Billion Singapore Manufacturing Facility	02:30am	MT
Correction: AstraZeneca Ordered to Pay $108 Million to Pfizer for Patent Violations	02:25am	MT
AstraZeneca to build $1.5-bln cancer drug plant in Singapore	02:17am	RE
AstraZeneca plans to build $1.5 billion manufacturing facility in Singapore	02:17am	RE
AstraZeneca Ordered to Pay $108 Million to Pfizer for Patent Violations	02:15am	MT
Pfizer wins $107.5 million from AstraZeneca in US cancer drug patent trial	May. 17	RE
AstraZeneca's Sipavibart Prevents COVID-19 in Immunocompromised Patients in Phase 3 Trial	May. 16	MT
Global markets live: Cisco, EasyJet, Roche, Netflix, Amazon...	May. 16
AstraZeneca trials yield positive results for immunocompromised patients	May. 16	AN
AstraZeneca: positive results in Covid prevention	May. 16	CF
The FTSE 100 is taking a breather	May. 16

AstraZeneca PLC is one of the world's leading pharmaceutical groups. Net sales break down by source of income as follows: - product sales (95.6%). Net sales break down by treatment area between oncology (39.2%), cardiovascular, renal and metabolic diseases (24.2%), respiratory and autoimmune diseases (13.9%), and other (22.7%; inflammatory diseases, neurological diseases, gastrointestinal and infectious diseases); - collaboration revenue (4.4%). Net sales are distributed geographically as follows: the United Kingdom (7.4%), Europe (21.2%), America (45.3%) and Africa-Asia-Australia (26.1%).

Sector

Pharmaceuticals

Calendar

12:15pm - American Thoracic Society Conference - Abstarct Number - P594

Related indices

STOXX EUROPE 600 (EUR) , FTSE 100

More about the company

Income Statement Evolution

More financial data

Analysis / Opinion

ASTRAZENECA : Strong Q1 raises hopes of a guidance upgrade

April 25, 2024 at 12:02 pm EDT

More Strategies

Ratings for AstraZeneca PLC

Trading Rating

Investor Rating

ESG Refinitiv

B+

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

153.7 USD

Average target price

167.9 USD

Spread / Average Target

+9.24%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

	1st Jan change	Capi.
ASTRAZENECA PLC	+14.11%	239B
ELI LILLY AND COMPANY	+34.35%	693B
NOVO NORDISK A/S	+29.39%	584B
JOHNSON & JOHNSON	-3.49%	372B
MERCK & CO., INC.	+20.15%	332B
ABBVIE INC.	+6.19%	294B
ROCHE HOLDING AG	-3.03%	211B
NOVARTIS AG	+10.02%	210B
AMGEN INC.	+9.21%	168B
PFIZER, INC.	-0.90%	162B

Other Pharmaceuticals

AstraZeneca PLC

Equities

AZN

GB0009895292

Pharmaceuticals

ASTRAZENECA : Deutsche Bank gives a Sell rating

Latest news about AstraZeneca PLC

Chart AstraZeneca PLC

Company Profile

Income Statement Evolution

Analysis / Opinion

Ratings for AstraZeneca PLC

Analysts' Consensus

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Other Pharmaceuticals